Gan & Lee Pharmaceuticals: Insulin Aspart Injection receives marketing authorization from the European Commission
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Golden Ten Data, May 6 – Gan & Lee Pharmaceuticals announced that the company and its wholly owned European subsidiary, Gan & Lee Europe, recently received notification from the European Commission that the company’s product, insulin aspart injection, has been granted marketing authorization in the European Union, Iceland, Liechtenstein, and Norway, for the treatment of diabetes in adults, adolescents, and children aged one year and older.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Retail investors return to AI! Citadel Securities: net buying of US stocks reached $9.1 billions last week, third highest chip stock purchases in a year
Retail investors, who once hesitated, are now returning to their favorite bet: artificial intelligence (AI).
智通财经•2026/10/13 22:51
HII wins $56 million US Navy contract for AUKUS submarine design support
Bitget•2026/10/13 22:21
Chinese Yuan: Outlook stays mildly positive against US Dollar – UOB
FXStreet•2026/10/13 21:18
Crypto prices
More
Bitcoin
BTC
$83,228.44
+1.68%
Ethereum
ETH
$2,500.43
+2.04%
Tether USDt
USDT
$0.9991
+0.03%
BNB
BNB
$742.6
+0.32%
XRP
XRP
$1.37
+1.65%
USDC
USDC
$0.9999
+0.00%
Solana
SOL
$106.69
+0.67%
TRON
TRX
$0.3272
-0.62%
Hyperliquid
HYPE
$81.54
-0.83%
Zcash
ZEC
$1,220.22
+1.89%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now